Spots Global Cancer Trial Database for al8326 middle dose group
Every month we try and update this database with for al8326 middle dose group cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC | NCT05363280 | Small Cell Lung... | AL8326 low dose... AL8326 middle d... AL8326 high dos... | 18 Years - | Advenchen Laboratories, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
